Pelvic Organ Prolapse Reconstruction with the Chitosan-Based Novel Haemostatic Agent in Ovine Model—Preliminary Report

Klaudia Stangel-Wójcikiewicz,Maciej Murawski,Tomasz Schwarz,Krzysztof Skotniczny,Agnieszka Fuchs,Jan Wolski,Julia Radwan-Pragłowska,Łukasz Janus,Marek Piątkowski,Marta Kot,Andrzej Wróbel,Dorota Wojtysiak,Przemysław Urbaniec
DOI: https://doi.org/10.3390/ijms25073801
IF: 5.6
2024-03-29
International Journal of Molecular Sciences
Abstract:This prospective study aimed to assess the feasibility of chitosan biomaterial and subcutaneous gel implantation in an ovine model, with implications for women with genital prolapse. Twenty-four ewes were divided into four groups (n = 6 per group): chitosan type B, chitosan type C, chitosan unmodified injections, and polypropylene mesh. Ovine models were chosen due to their morphological resemblance to human reproductive organs. Animals were sacrificed after 90 days for macroscopic, pathomorphological, and immunohistochemical analysis. In the chitosan type B group, IL-6 and IL-10 levels decreased after 28 days, while chitosan type C and injection groups exhibited higher IL-6 than IL-10 levels. The polypropylene group displayed the highest IL-6 and lowest IL-10 levels. Histological examination of the polypropylene group revealed no degenerative changes or inflammation, whereas chitosan injection induced local inflammation. Other groups exhibited no degenerative changes. Ewes implanted with chitosan displayed reduced inflammation compared to polypropylene-implanted ewes. Chitosan implantation facilitated vaginal tissue healing, in contrast to polypropylene mesh, which led to extrusion. While chitosan holds promise as an alternative to polypropylene mesh, further research is imperative for comprehensive evaluation. This study suggests the potential of a chitosan biomaterial in pelvic organ prolapse treatment, warranting additional investigation.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the feasibility of using a new chitosan - based hemostatic agent in gynecological surgery for pelvic organ prolapse reconstruction. Specifically, the study aims to evaluate the immunological and pathomorphological responses of chitosan materials in a sheep model, as well as its potential as an alternative to polypropylene mesh in the treatment of female pelvic organ prolapse. ### Research Background Pelvic organ prolapse (POP) is a common gynecological disease, affecting more than 50% of post - menopausal women. Currently, common treatment methods include tissue transplantation and artificial implants, but these methods have certain limitations and complications, such as vaginal, bladder or rectal exposure and erosion. Therefore, finding a safer and more effective alternative material has become the focus of research. ### Research Objectives 1. **Evaluate the Feasibility of Chitosan Materials**: By implanting chitosan materials in a sheep model, evaluate its feasibility and biocompatibility in the treatment of pelvic organ prolapse. 2. **Compare Different Types of Chitosan Materials**: Study the immunological and pathomorphological responses of different types of chitosan materials (type B, type C, and unmodified chitosan injection). 3. **Compare with Polypropylene Mesh**: Compare the performance of chitosan materials with the commonly used polypropylene mesh, and evaluate its advantages in reducing inflammatory responses and promoting tissue healing. ### Experimental Design - **Animal Model**: Select 24 sheep and divide them into four groups, with 6 sheep in each group: - Chitosan type B group - Chitosan type C group - Unmodified chitosan injection group - Polypropylene mesh group - **Experimental Method**: Implant chitosan materials or polypropylene mesh under the anterior vaginal wall of sheep, and perform macroscopic, pathomorphological and immunohistochemical analyses after 90 days. ### Main Results - **Inflammatory Response**: - In the chitosan type B group, the levels of IL - 6 and IL - 10 decreased on the 28th day, showing an anti - inflammatory effect. - In the chitosan type C group and the injection group, the level of IL - 6 was higher than that of IL - 10 on the 28th day. - The polypropylene mesh group showed the highest level of IL - 6 and the lowest level of IL - 10. - **Histological Examination**: - No degenerative changes or inflammation were found in the polypropylene mesh group. - The chitosan injection group caused local inflammation. - No degenerative changes were found in the other groups. - **Healing Situation**: - Sheep implanted with chitosan showed less inflammatory response and contributed to vaginal tissue healing. - The polypropylene mesh group led to material exposure. ### Conclusion The study shows that chitosan materials have potential application value in the treatment of pelvic organ prolapse, especially in reducing inflammatory responses and promoting tissue healing. However, further research is still needed to comprehensively evaluate its safety and effectiveness.